A safety study of ultra‐high dose rate FLASH radiotherapy in the treatment of superficial skin tumors: study protocol of a phase I trial (ChiCTR2400080935)
Precision Radiation Oncology · 2025-06 · 9 (2) · 72-76
DOI: 10.1002/pro6.70010 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Precision Radiation Oncology, online erschienen am 05.04.2025. Verfasst von Chengliang Yang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology The Affiliated Cancer Hospital of Zhengzhou University& Henan Cancer Hospital Zhengzhou China. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Ultra‐high dose rate FLASH radiotherapy (FLASH‐RT) is emerging as a novel technique to improve the normal tissue tolerance by delivering ultra‐high dose rate radiation several orders of magnitude higher than convention radiotherapy. It has been shown in preclinical studies to cause less injury to surrounding normal tissues during radiation treatment, while still maintaining local tumor control. The purpose of this protocol is to evaluate the safety of fractionated FLASH‐RT in skin cancer.
Method
Patients with superficial skin tumors will be enrolled. The eligible patients will undergo electron FLASH‐RT (24‐40 Gy/3‐5 fractions) to the tumor volume. The primary outcome is to evaluate the safety of FLASH‐RT by collecting the acute (< 90 days) skin toxicity adverse events of radiation according to Common Terminology Criteria for Adverse Events (CTCAE) version 5.0. Secondary objectives include late (> 90 days) skin toxicity after FLASH‐RT according to CTCAE version 5.0 and treatment response.
Discussion
If the results show that delivering FLASH‐RT is safe and feasible for skin tumors, further investigation will be conduct to evaluate efficacy of FLASH‐RT in a phase II trial. Trial Registration number ChiCTR2400080935. https://www.chictr.org.cn/showproj.html?proj=220336
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology The Affiliated Cancer Hospital of Zhengzhou University& Henan Cancer Hospital Zhengzhou China.
ORCID-Profile: Hui Luo
Zitieren
APA
Yang, C., Luo, H., Leijie, M., Mao, R., Lei, H., Zhang, Y., Xu, M., Wang, Y., Wu, M., Liu, H., Chen, P., & Ge, H. (2025). A safety study of ultra‐high dose rate FLASH radiotherapy in the treatment of superficial skin tumors: study protocol of a phase I trial (ChiCTR2400080935). Precision Radiation Oncology, 9(2), 72-76. https://doi.org/10.1002/pro6.70010
Vancouver
Yang C, Luo H, Leijie M, Mao R, Lei H, Zhang Y, et al. A safety study of ultra‐high dose rate FLASH radiotherapy in the treatment of superficial skin tumors: study protocol of a phase I trial (ChiCTR2400080935). Precision Radiation Oncology. 2025;9(2):72-76. doi:10.1002/pro6.70010
BibTeX
@article{Yang2025,
author = {Yang, Chengliang and Luo, Hui and Leijie, Ma and Mao, Ronghu and Lei, Hongchang and Zhang, Yanping and Xu, Meng and Wang, Yiwu and Wu, Mingxia and Liu, Han and Chen, Peng and Ge, Hong},
title = {A safety study of ultra‐high dose rate FLASH radiotherapy in the treatment of superficial skin tumors: study protocol of a phase I trial (ChiCTR2400080935)},
journal = {Precision Radiation Oncology},
year = {2025},
volume = {9},
number = {2},
pages = {72--76},
doi = {10.1002/pro6.70010}
}
EUVIMED